Published in J Virol on December 01, 1999
Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol (2005) 3.82
Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol (2001) 3.80
Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis (2007) 3.79
Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis (2003) 2.98
Emerging viral diseases of Southeast Asia and the Western Pacific. Emerg Infect Dis (2001) 2.91
Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med (2009) 2.73
Viral quasispecies evolution. Microbiol Mol Biol Rev (2012) 2.69
Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol (2002) 2.64
Frequency and dynamics of recombination within different species of human enteroviruses. J Virol (2006) 2.64
Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol (2010) 2.50
Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol (2009) 2.40
Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol (2006) 2.33
Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol (2005) 2.26
Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J Clin Microbiol (2008) 2.24
Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J Clin Microbiol (2009) 2.11
The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One (2011) 1.96
Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol (2008) 1.85
Seroepidemiology of human enterovirus 71, Singapore. Emerg Infect Dis (2002) 1.81
Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections. Rev Med Virol (2014) 1.76
Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008. J Clin Microbiol (2009) 1.69
Emergence and transmission pathways of rapidly evolving evolutionary branch C4a strains of human enterovirus 71 in the Central Plain of China. PLoS One (2011) 1.67
Molecular epidemiology and evolution of human enterovirus serotype 68 in Thailand, 2006-2011. PLoS One (2012) 1.66
Human enterovirus 71 epidemics: what's next? Emerg Health Threats J (2013) 1.54
Enterovirus 71 outbreak, Brunei. Emerg Infect Dis (2009) 1.54
High prevalence of human enterovirus a infections in natural circulation of human enteroviruses. J Clin Microbiol (2006) 1.47
An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol (2007) 1.41
The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71. J Virol (2011) 1.40
Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: improved primers for the specific detection of human enterovirus 71 by RT PCR. BMC Infect Dis (2004) 1.39
Complete genome analysis of the C4 subgenotype strains of enterovirus 71: predominant recombination C4 viruses persistently circulating in China for 14 years. PLoS One (2013) 1.36
Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity. PLoS One (2014) 1.33
Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother (2013) 1.31
Genetic diversity and C2-like subgenogroup strains of enterovirus 71, Taiwan, 2008. Virol J (2010) 1.26
Transmission networks and population turnover of echovirus 30. J Virol (2008) 1.25
Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One (2012) 1.24
Host factors in enterovirus 71 replication. J Virol (2011) 1.19
Molecular characterization of human enteroviruses in the Central African Republic: uncovering wide diversity and identification of a new human enterovirus A71 genogroup. J Clin Microbiol (2012) 1.16
Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol (2012) 1.16
Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot-Mouth Disease after recovery. BMC Infect Dis (2010) 1.15
The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments. Virol J (2010) 1.12
Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci (2014) 1.12
Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16. J Clin Microbiol (2006) 1.12
Antigenic and receptor binding properties of enterovirus 68. J Virol (2013) 1.11
Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One (2013) 1.10
Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS One (2013) 1.09
Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog (2012) 1.08
Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J Virol (2002) 1.08
Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified. PLoS One (2013) 1.08
Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog (2013) 1.07
Enterovirus genotypes causing hand foot and mouth disease in Shanghai, China: a molecular epidemiological analysis. BMC Infect Dis (2013) 1.06
Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages. J Virol (2002) 1.06
Identification of a novel feline picornavirus from the domestic cat. J Virol (2011) 1.05
Fatal case of enterovirus 71 infection, France, 2007. Emerg Infect Dis (2009) 1.05
Serotype-specific detection of coxsackievirus A16 in clinical specimens by reverse transcription-nested PCR. J Clin Microbiol (2001) 1.04
Evolutionary dynamics and temporal/geographical correlates of recombination in the human enterovirus echovirus types 9, 11, and 30. J Virol (2010) 1.03
Prospective identification of enteroviruses involved in meningitis in 2006 through direct genotyping in cerebrospinal fluid. J Clin Microbiol (2007) 1.03
The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model. PLoS Pathog (2015) 1.03
Aseptic meningitis in Germany associated with echovirus type 13. BMC Infect Dis (2001) 1.00
The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children. PLoS One (2013) 1.00
Fluoxetine is a potent inhibitor of coxsackievirus replication. Antimicrob Agents Chemother (2012) 0.99
Molecular phylogeny of Coxsackievirus A16 in Shenzhen, China, from 2005 to 2009. J Clin Microbiol (2011) 0.97
Seroepidemiology and molecular epidemiology of enterovirus 71 in Russia. PLoS One (2014) 0.97
Characterization of a putative ancestor of coxsackievirus B5. J Virol (2010) 0.96
Genus-specific substitution rate variability among picornaviruses. J Virol (2011) 0.96
Development and evaluation of a reverse transcription-loop-mediated isothermal amplification assay for rapid detection of enterovirus 71. J Clin Microbiol (2010) 0.95
A highly divergent Encephalomyocarditis virus isolated from nonhuman primates in Singapore. Virol J (2013) 0.91
Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J (2012) 0.91
Molecular epidemiology of enterovirus 71 infection in the central region of Taiwan from 2002 to 2012. PLoS One (2013) 0.90
Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China. Mol Med Rep (2012) 0.90
Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010. PLoS One (2012) 0.89
Molecular classification of enteroviruses not identified by neutralization tests. Emerg Infect Dis (2002) 0.89
Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012, Taiwan. PLoS One (2013) 0.89
Development and evaluation of a non-ribosomal random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot and mouth disease pathogens. Virol J (2016) 0.88
Cell and tissue tropism of enterovirus 71 and other enteroviruses infections. J Biomed Sci (2014) 0.88
Recombination in enteroviruses is a biphasic replicative process involving the generation of greater-than genome length 'imprecise' intermediates. PLoS Pathog (2014) 0.87
Epidemiological Characteristics and Spatial-Temporal Clusters of Hand, Foot, and Mouth Disease in Zhejiang Province, China, 2008-2012. PLoS One (2015) 0.87
Recombinant Enterovirus A71 Subgenogroup C1 Strains, Germany, 2015. Emerg Infect Dis (2016) 0.87
A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses. PLoS One (2012) 0.87
Rooting human parechovirus evolution in time. BMC Evol Biol (2009) 0.86
Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro. PLoS One (2013) 0.85
Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay. PLoS One (2014) 0.85
Recent developments in antiviral agents against enterovirus 71 infection. J Biomed Sci (2014) 0.85
Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s. BMC Microbiol (2011) 0.84
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game. J Virol (2015) 0.84
Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71. PLoS One (2013) 0.84
Molecular epidemiology and recombination of human enteroviruses from AFP surveillance in Yunnan, China from 2006 to 2010. Sci Rep (2014) 0.84
Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression. PLoS One (2014) 0.83
RNA polymerase I-driven reverse genetics system for enterovirus 71 and its implications for vaccine production. Virol J (2012) 0.83
Mapping genetic determinants of the cell-culture growth phenotype of enterovirus 71. J Gen Virol (2011) 0.83
Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice. PLoS One (2013) 0.83
Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution. J Virol (2015) 0.82
Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis. Virol J (2015) 0.82
Daphne Genkwa sieb. Et zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry. Viruses (2012) 0.82
Conformational plasticity of the 2A proteinase from enterovirus 71. J Virol (2013) 0.82
The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine Development. Int J Environ Res Public Health (2016) 0.81
Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations. BMC Med (2015) 0.80
Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine. PLoS Negl Trop Dis (2013) 0.80
Inferring nonneutral evolution from contrasting patterns of polymorphisms and divergences in different protein coding regions of enterovirus 71 circulating in Taiwan during 1998-2003. BMC Evol Biol (2010) 0.80
Mutations in the non-structural protein region contribute to intra-genotypic evolution of enterovirus 71. J Biomed Sci (2014) 0.80
Complete genome sequence of a human enterovirus 71 strain isolated from a fatal case in shanghai, china, in 2012. Genome Announc (2014) 0.79
A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes. Mol Biol Evol (1985) 10.67
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis (1974) 6.22
Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet (1998) 3.78
Fatal enterovirus 71 encephalomyelitis. J Pediatr (1998) 3.39
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31
Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J Infect Dis (1986) 3.01
Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res (1995) 2.98
Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol (1979) 2.80
Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol (1982) 2.67
Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J (1988) 2.32
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet (1974) 2.16
Enterovirus type 71 infection in Melbourne. Bull World Health Organ (1974) 2.16
Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology (1994) 2.13
Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis (1984) 2.09
Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child (1980) 1.96
Deaths among children during an outbreak of hand, foot, and mouth disease--Taiwan, Republic of China, April-July 1998. MMWR Morb Mortal Wkly Rep (1998) 1.87
Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J (1987) 1.81
Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatr Infect Dis J (1989) 1.67
Isolation of a new enterovirus (38506). Proc Soc Exp Biol Med (1975) 1.40
Fatal enterovirus type 71 infection: rapid detection and diagnostic pitfalls. Pediatr Infect Dis J (1995) 1.37
Molecular evolution of the major capsid protein VP1 of enterovirus 70. J Virol (1994) 1.29
Enterovirus 71 infection: report of an outbreak with two cases of paralysis and a review of the literature. Pediatrics (1981) 1.07
Epidemic of hand, foot and mouth disease in Japan. Jpn J Med Sci Biol (1973) 0.92
Outbreak of hand, foot and mouth disease in Sarawak. Cluster of deaths among infants and young children. Wkly Epidemiol Rec (1997) 0.91
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol (1999) 5.08
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03
Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol (2000) 3.99
An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol (2011) 3.80
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31
Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res (1995) 2.98
Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol (1981) 2.81
Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet (1996) 2.72
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis (1999) 2.44
Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci (1998) 2.43
Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus. Virology (1990) 2.36
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med (2000) 2.35
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33
Protein processing map of poliovirus. J Virol (1984) 2.33
Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J (1988) 2.32
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Enterovirus type 71 infection in Melbourne. Bull World Health Organ (1974) 2.16
Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis (1997) 2.16
Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis (1999) 2.03
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus. J Virol (1997) 1.81
New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum (1997) 1.78
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses. Virus Res (1998) 1.74
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71
Molecular epidemiology of adenoviruses: global distribution of adenovirus 7 genome types. J Clin Microbiol (1985) 1.64
Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol (1999) 1.62
Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5' end of the region encoding VP2. Virus Res (1998) 1.61
Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci (2001) 1.60
An epidemic associated with echovirus type 18. J Hyg (Lond) (1972) 1.57
Echovirus 22 is an atypical enterovirus. J Virol (1990) 1.55
Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol (2001) 1.53
Enteroviruses as agents of emerging infectious diseases. J Neurovirol (2005) 1.51
Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis (1996) 1.47
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg (1997) 1.45
Serotype-specific identification of enterovirus 71 by PCR. J Clin Virol (2000) 1.44
Vaccine-associated paralytic poliomyelitis. N Engl J Med (1993) 1.39
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region. Am J Trop Med Hyg (1998) 1.30
National surveillance for respiratory syncytial virus, United States, 1985-1990. J Infect Dis (1994) 1.21
Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods (1993) 1.19
Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center. J Infect Dis (1994) 1.15
Audit in intensive care. The APACHE II classification of severity of disease. Ulster Med J (1990) 1.13
Measuring the continuity and coordination of medical care in a system involving multiple providers. Med Care (1984) 1.13
A study of the prevalence of rotavirus infection in children with gastroenteritis admitted to an infectious diseases hospital. J Med Virol (1977) 1.10
Comparison of rhinovirus-sensitive HeLa cells and human embryo fibroblasts for isolation of rhinoviruses from patients with respiratory disease. J Clin Microbiol (1976) 1.10
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci (1993) 1.07
The 1976 influenza epidemic in Melbourne. Med J Aust (1978) 1.07
Reflex disturbances of cardiac rhythm during ophthalmic surgery. Br J Ophthalmol (1975) 1.07
Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol (1998) 1.07
A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol (1990) 1.05
Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology (1991) 1.04
Specific detection of echoviruses 22 and 23 in cell culture supernatants by RT-PCR. J Med Virol (1999) 1.02
Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol (1993) 1.01
Hand, foot and mouth disease: an outbreak with interesting virological features. Pathology (1973) 1.00
Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer (1998) 0.99
High degree of genetic diversity of non-polio enteroviruses identified in Georgia by environmental and clinical surveillance, 2002-2005. J Med Microbiol (2010) 0.99
Distribution of wild type 1 poliovirus genotypes in China. J Infect Dis (1993) 0.96
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination. Ann N Y Acad Sci (1995) 0.96
Acute hemorrhagic conjunctivitis due to enterovirus 70 in American Samoa: serum-neutralizing antibodies and sex-specific protection. Am J Epidemiol (1992) 0.96
Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. Emerg Infect Dis (2001) 0.95
Viruses and virus-like particles in the faeces of dogs with and without diarrhoea. Aust Vet J (1984) 0.94
Type-specific detection of echovirus 30 isolates using degenerate reverse transcriptase PCR primers. J Clin Microbiol (2001) 0.94
Outbreak of paralytic poliomyelitis in a highly immunized population in Jordan. J Infect Dis (1997) 0.93
Chronic group A coxsackievirus infection in agammaglobulinemia: demonstration of genomic variation of serotypically identical isolates persistently excreted by the same patient. J Infect Dis (1988) 0.93
Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3. J Med Virol (1997) 0.93
Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. J Gen Virol (1995) 0.93
An outbreak of acute haemorrhagic conjunctivitis in Melaka, Malaysia. Singapore Med J (2003) 0.93
Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Curr Eye Res (1997) 0.92
Virus and virus-like particles in the faeces of cats with and without diarrhoea. Aust Vet J (1987) 0.92
Biochemical disturbances associated with total hip replacement. J Bone Joint Surg Br (1979) 0.91
Dysrhythmia and oral surgery. Br J Anaesth (1971) 0.90
Vaccine-preventable disease susceptibility in a young adult Micronesian population. Southeast Asian J Trop Med Public Health (1994) 0.88
Immunity to hepatitis B, poliomyelitis and measles in fully vaccinated aboriginal and Torres Strait Island children. J Paediatr Child Health (1995) 0.87
Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation. J Immunother Emphasis Tumor Immunol (1994) 0.87
A theoretical framework for evaluating the sensitivity of surveillance for detecting wild poliovirus: II. Factors affecting detection sensitivity in a population with circulating wild poliovirus. J Infect Dis (1997) 0.86
Selenium deficiency during total parenteral nutrition--a case report. Ulster Med J (1982) 0.86